Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Desrayaud

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|March 3, 2012
Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptidesHeinrich Rueeger, Rainer Lueoend, Olivier Rogel, et al.
Journal of Neurochemistry|April 12, 2006
Hyperdopaminergia and altered locomotor activity in GABAB1-deficient miceClaire-Marie Vacher, Martin Gassmann, Sandrine Desrayaud, et al.
Bioorganic & Medicinal Chemistry|October 16, 2014
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterizationIvo Vranesic, Silvio Ofner, Peter Josef Flor, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 24, 2015
Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urineJoachim Blanz, Thierry Délémonté, David Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2013
Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid β-peptidesHeinrich Rueeger, Rainer Lueoend, Rainer Machauer, et al.
Chemmedchem|November 19, 2016
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor AntagonistDavid Orain, Engin Tasdelen, Samuel Haessig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 5, 2018
Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in miceRowan Stringer, Valerie Cordier, Catherine Afatsawo, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivoRainer Machauer, Kurt Laumen, Siem Veenstra, et al.
Acta Neuropathologica Communications|February 17, 2018
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945Nicolau Beckmann, Elisa Giorgetti, Anna Neuhaus, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonistsDavid Orain, Silvio Ofner, Manuel Koller, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|March 3, 2012
Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptidesHeinrich Rueeger, Rainer Lueoend, Olivier Rogel, et al.
Journal of Neurochemistry|April 12, 2006
Hyperdopaminergia and altered locomotor activity in GABAB1-deficient miceClaire-Marie Vacher, Martin Gassmann, Sandrine Desrayaud, et al.
Bioorganic & Medicinal Chemistry|October 16, 2014
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterizationIvo Vranesic, Silvio Ofner, Peter Josef Flor, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 24, 2015
Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urineJoachim Blanz, Thierry Délémonté, David Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2013
Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid β-peptidesHeinrich Rueeger, Rainer Lueoend, Rainer Machauer, et al.
Chemmedchem|November 19, 2016
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor AntagonistDavid Orain, Engin Tasdelen, Samuel Haessig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 5, 2018
Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in miceRowan Stringer, Valerie Cordier, Catherine Afatsawo, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivoRainer Machauer, Kurt Laumen, Siem Veenstra, et al.
Acta Neuropathologica Communications|February 17, 2018
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945Nicolau Beckmann, Elisa Giorgetti, Anna Neuhaus, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonistsDavid Orain, Silvio Ofner, Manuel Koller, et al.
Pageof 4